Adjuvant hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with colon cancer at high risk of peritoneal carcinomatosis; the COLOPEC randomized multicentre trial

BACKGROUND: The peritoneum is the second most common site of recurrence in colorectal cancer. Early detection of peritoneal carcinomatosis (PC) by imaging is difficult. Patients eventually presenting with clinically apparent PC have a poor prognosis. Median survival is only about five months if untr...

Descripción completa

Detalles Bibliográficos
Autores principales: Klaver, Charlotte E L, Musters, Gijsbert D, Bemelman, Willem A, Punt, Cornelis J A, Verwaal, Victor J, Dijkgraaf, Marcel GW, Aalbers, Arend GJ, van der Bilt, Jarmila DW, Boerma, Djamila, Bremers, Andre JA, Burger, Jacobus WA, Buskens, Christianne J, Evers, Pauline, van Ginkel, Robert J, van Grevenstein, Wilhelmina MU, Hemmer, Patrick HJ, de Hingh, Ignace HJT, Lammers, Laureen A, van Leeuwen, Barbara L, Meijerink, Wilhelmus JHJ, Nienhuijs, Simon W, Pon, Jolien, Radema, Sandra A, van Ramshorst, Bert, Snaebjornsson, Petur, Tuynman, Jurriaan B, te Velde, Elisabeth A, Wiezer, Marinus J, de Wilt, Johannes HW, Tanis, Pieter J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4492087/
https://www.ncbi.nlm.nih.gov/pubmed/26003804
http://dx.doi.org/10.1186/s12885-015-1430-7

Ejemplares similares

Ejemplares similares